Adagene Inc. Insider Trading Report

This filing details stock options granted to Ulf Grawunder, a director at Adagene Inc. Two grants of nonqualified stock options are reported: 40,000 options with an exercise price of $2.26, granted on April 8, 2024, vesting 50% on each of the first two anniversaries. Additionally, 25,000 options with an exercise price of $2.032, granted on February 5, 2026, vesting 25% on each of the first four anniversaries. Mr. Grawunder directly holds 25,000 ordinary shares of Adagene Inc. The report was signed on March 17, 2026.